Guardian Point Capital’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Guardian Point Capital’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,200,000	Closed	-$4.1M	–	20
2021 Q3	$4.1M	Hold	1,200,000	–	–	0.95%	17
2021 Q2	$3.59M	Hold	1,200,000	–	–	0.81%	17
2021 Q1	$3.88M	Buy	+1,200,000	New	+$4M	0.97%	18

Other funds holding INFI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Guardian Point Capital's INFI Position: Q4 2021 in Review

Guardian Point Capital sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2021, closing a stake of 1,200,000 shares — an estimated $4.1M sold.

Guardian Point Capital first reported a position in INFI in Q1 2021 and held it in 3 quarters. The position peaked at $4.1M in Q3 2021. 97 funds tracked by Wall St. Rank hold INFI as of Q4 2021.

Guardian Point Capital reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Guardian Point Capital sold 1,200,000 Infinity Pharmaceuticals, Inc. shares in Q4 2021, an estimated $4.1M.
Guardian Point Capital first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2021 and held it in 3 quarters.
Guardian Point Capital's Infinity Pharmaceuticals, Inc. position peaked at $4.1M in Q3 2021.
97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2021.

Based on Guardian Point Capital's 13F filing for Q4 2021, filed 14 Feb 2022.